An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by the Body
- Status
- COMPLETED
- Phase
- PHASE1
The Effect of AMG 133 on Gastric Emptying
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic Function
- Status
- COMPLETED
- Phase
- PHASE1
Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
- Status
- COMPLETED
- Phase
- PHASE1
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
- Status
- RECRUITING
- Phase
- PHASE3
Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta
- Status
- RECRUITING
- Phase
- PHASE3
Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations
- Status
- COMPLETED
- Phase
- PHASE1
A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity
- Status
- COMPLETED
- Phase
- PHASE1
Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
- Status
- RECRUITING
- Phase
- PHASE1
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
- Status
- RECRUITING
- Phase
- PHASE3
A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations
- Status
- COMPLETED
- Phase
- PHASE1